-
February 17: The Week in Cancer NewsMore older women with breast cancer may not need radiation therapy, and supply shortages hinder bladder cancer treatment.
by Kevin McLaughlin
-
Spouses of Cancer Patients Have Greater Risk of Psychiatric DisordersMental health support in the wake of a cancer diagnosis often doesn’t extend to spouses.
by Karon Warren
-
February 10: The Week in Cancer NewsPatients who receive certain forms of chemo face long-term risk for heart failure, and screening levels for certain cancers remain below expectations.
by Thomas Celona
-
Consider Immunotherapy Before Surgery for MelanomaImmunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
-
February 3: The Week in Cancer NewsGroup says more women should consider removing fallopian tubes to lower ovarian cancer risk, and treatment guidelines can lead to arbitrary age cutoffs.
by Eric Fitzsimmons
-
January 27: The Week in Cancer NewsMany women underestimate dense breast effect on cancer risk, and FDA approves targeted therapy for colorectal cancer.
by Kevin McLaughlin
-
An Evidence-Based Guide to Integrative MedicineASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
-
January 20: The Week in Cancer NewsWomen experience faster decline in physical function after cancer, and treatment quality for lung cancer varies across the US.
by Marci A. Landsmann
-
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
-
January 13: The Week in Cancer NewsWomen over 65 diagnosed at later stages of cervical cancer, and Black and Hispanic patients prescribed fewer opioids for end-of-life cancer care.
by Eric Fitzsimmons
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
